查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1363022

內分泌檢測市場規模、佔有率和趨勢分析報告：按檢測類型、技術、最終用途、地區、細分趨勢，2023-2030

Endocrine Testing Market Size, Share & Trends Analysis Report By Test Type (FSH, Insulin), By Technology (Tandem Mass Spectrometry, Immunoassay), By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10個工作天內

價格

內分泌檢測市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球內分泌檢測市場規模預計將達到214.2億美元，預測期內年複合成長率為8.4%。

成人和老年族群中肥胖、糖尿病和甲狀腺等文明病的患病日益增加，推動了對內分泌檢測的需求。定期對個人進行內分泌檢測有助於維持整體健康，因此更好的健康意識對全球內分泌檢測市場的成長做出了重大貢獻。

根據世界衛生組織統計，2020年有超過3,900萬五歲以下兒童超重或肥胖。久坐的生活方式和不健康的用餐選擇會導致一般人群肥胖和糖尿病。此類疾病的發生促使人們對代謝功能和相關荷爾蒙失調進行了大量研究。

政府和私人組織的財政支持也激勵科學界。例如，NIH 的 NIDDK（國家糖尿病、消化和腎臟疾病研究所）促進了許多資助的研究項目，旨在透過更好地了解疾病來改善健康。 NIDDK 的此類配合措施之一是 2022 年 9 月舉辦的大西洋中部糖尿病和肥胖研究研討會。這使得科學知識的替換和交流成為可能，並實現區域層面的合作。這些配合措施預計將增進對人體分泌功能的了解，並進一步促進內分泌檢測市場的成長。

欠低度開發國家和新興國家缺乏認知預計將減緩內分泌檢測市場的成長。不斷發展的醫療環境和缺乏報銷模式阻礙了這些地區的個人接受定期內分泌檢查。然而，隨著 COVID-19大流行期間人們對健康系統的認知增強，預計這些國家的檢測頻率將會增加。

COVID-19疫情為內分泌檢測的應用創造了有利的機會。 COVID-19 感染會導致損害許多器官的全身性疾病。因此，這些患者存在許多代謝和荷爾蒙紊亂，導致內分泌研究的增加。例如，2021 年 3 月，內分泌學會成員核准了100 億美元用於支持 COVID-19 研究，以識別和了解 COVID-19 對內分泌系統的短期和長期影響。同樣，2020 年 9 月，美國糖尿病協會在各種研究項目中投資了 100 萬美元，以調查糖尿病與 COVID-19 之間的關聯。因此，需求增加並進一步推動市場成長。

此外，由於隔離而造成的行動限制和限制也鼓勵了醫療諮詢和家庭樣本收集服務的數位平台的發展。用於在家檢測荷爾蒙水平的照護端設備和套件的可用性也推動了整個內分泌檢測市場的成長。

由於預計內分泌檢測市場成長的各種要素，市場參與者也在擴大其區域業務。合作、夥伴關係和全球擴張是主要參與者推動產生收入的一些業務策略。例如，2022年2月，美國控股實驗室公司（Labcorp）宣佈在美國美國開設新實驗室。印第安納州南本德的新診斷業務將增強該公司的服務，並為該地區的患者和醫生提供服務。

內分泌檢測市場報告亮點

  • 依檢測類型分類，2022年人類絨毛膜促性腺激素（hCG）荷爾蒙檢測佔最大佔有率。這是由於藥房中存在自我檢測套組，以及用於定量評估的實驗室和醫院檢測。此外，懷孕不同周期間的檢測頻率和大量生育婦女也發揮了作用。
  • 從技術角度來看，免疫分析在 2022 年佔據市場主導地位。這是由於主要企業的設備使用基於免疫分析的檢測技術。許多依賴免疫分析技術的儀器和測試面板正在推動內分泌測試市場的成長。
  • 以最終用途，商業實驗室對 2022 年的銷售額貢獻顯著。內分泌和生殖功能多樣化測試組的可行性和可用性、家庭收集等服務以及數位平台的存在正在導致細分市場佔有率的成長。
  • 2022年，北美將成為內分泌檢測市場銷售額最高的地區。這是由於美國口中甲狀腺疾病、糖尿病和肥胖症的盛行率很高。此外，該地區的醫療發展和支出模式的增加也導致了收益的增加。

目錄

第1章 調查方法與範圍

第2章 執行摘要

第3章 內分泌檢測市場變數、趨勢、範圍

  • 市場體系預測
    • 母市場預測
    • 相關/附隨市場預測
  • 普及和成長預測圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 內分泌檢測市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 內分泌檢測：檢測類型的估計與趨勢分析

  • 內分泌檢測市場：要點
  • 內分泌檢測市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 雌二醇（E2）測試
  • 濾泡刺激素(FSH) 測試
  • 人類絨毛膜促性腺激素 (hCG) 荷爾蒙測試
  • 黃體激素（LH）測試
  • 硫酸去氫表雄酮（DHEAS）測試
  • 黃體酮測試
  • 睪酮測試
  • 甲狀腺刺激素（TSH）測試
  • 催乳素測試
  • 皮質醇測試
  • 胰島素測試
  • 其他

第5章 內分泌檢測：技術預估與趨勢分析

  • 內分泌檢測市場：要點
  • 內分泌檢測市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 串聯質譜法
  • 免疫測定法
  • 單株和多株抗體技術
  • 感測器技術
  • 臨床化學
  • 其他

第6章 內分泌檢測：最終用途估計和趨勢分析

  • 內分泌檢測市場：要點
  • 內分泌檢測市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 醫院
  • 商業實驗室
  • 門診治療中心
  • 其他

第7章 內分泌檢測市場：區域估算及趨勢分析

  • 區域預測
  • 按地區分類的內分泌檢測市場：市場要點
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第8章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • Abbott Laboratories
    • AB Sciex
    • Agilent Technologies Inc.
    • bioMerieux SA
    • Bio-Rad Laboratories Inc.
    • DiaSorin SpA
    • F. Hoffmann-La Roche Ltd.
    • Laboratory Corporation of America Holdings
    • Quest Diagnostics Incorporated
    • Ortho Clinical Diagnostics
Product Code: 978-1-68038-862-6

Endocrine Testing Market Growth & Trends:

The global endocrine testing market size is expected to reach USD 21.42 billion by 2030, registering a CAGR of 8.4% during the forecast period, according to a new report by Grand View Research, Inc.. The growing prevalence of life style diseases such as obesity coupled with diabetes & thyroid among the adult as well as the geriatric population is driving the need for endocrine testing. The routine endocrine testing in individuals will help in overall maintenance of health and thus this awareness of better health is significantly contributing to the global endocrine testing market growth.

As per the statistics by WHO, more than 39 million children in 2020 who were under the age of 5 were overweight or obese. The sedentary life along with unhealthy diet choices have contributed to obesity as well as diabetes in the general population. This occurrence of diseased conditions has also prompted many researches into the metabolic functions and related hormonal disorders.

Funding from government and private organizations has also driven the scientific community. For instance, the NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases) by NIH drives many sponsored research programs towards improving health by better understanding of diseases. One such effort by NIDDK was the mid-atlantic symposium conducted in September 2022 for diabetes and obesity research. This will enable scientific knowledge exchange and interactions and allow collaboration at the regional level. Such initiatives will drive the understanding of endocrine function in the human body and will further enable the endocrine testing market growth.

The lack of awareness in underdeveloped and developing countries is anticipated to slow the growth of endocrine testing market. The developing health care settings and absence of reimbursement models restrain the individuals in these regions to undergo routine endocrine testing. However, with the growing consciousness of a healthy system during the COVID-19 pandemic is expected to upswing the testing frequency for these countries as well.

The outbreak of COVID-19 has created lucrative opportunities for the application of endocrine testing. COVID-19 infections cause a systemic disease that injures many organs. Therefore, these patients have many metabolic and hormonal disturbances that led to an increase in the number of endocrine research. For instance, in March 2021, Endocrine society members sanctioned USD 10 billion to support COVID-19 research to identify and understand the short and long-term COVID-19 effects on the endocrine system. Similarly, in September 2020, The American Diabetes Association invested USD 1 million to fund various research projects for investigating the link between diabetes and COVID-19. Thus, it will increase the demand and further boost market growth.

In addition, the limitation of movement and restrictions due to the lockdown encouraged the digital platform for medical consultation and at home sample collection services as well. The availability of point-of-care devices and kits for the detection of hormone levels at home is also driving the overall growth of endocrine testing market.

The market players are also expanding their regional presence due to various factors that are anticipated to grow the endocrine testing market. Collaboration, partnerships and global expansions are some of the business strategies by the key players to drive revenue generation. For instance, in February 2022 Laboratory Corporation of America Holdings (Labcorp) announced opening of a new laboratory in Indiana, U.S. The new diagnostics business in South Bend, Indiana will enhance the company's services and make their offerings accessible to both patients as well as physicians in this region.

Endocrine Testing Market Report Highlights:

  • By test type, the human Chorionic Gonadotropin (hCG) hormone testing accounted for the largest share in 2022, driven by the presence of self-test kits at pharmacy stores, along with tests in laboratories or hospitals for quantitative evaluation. Moreover, the frequency of testing during different weeks of pregnancy and high number of fertile female population are also the contributing factors.
  • By technology, immunoassay dominated the 2022 market, owing to the presence of instruments by key players which uses immunoassay-based detection techniques. The large number of instruments and test panels which rely on immunoassay technology, drives the endocrine testing market growth.
  • By end-user, commercial laboratories contributed majorly to the revenue generation in 2022. The feasibility & availability of variety of testing panels for endocrinology and reproductive functions, services like at home collection and presence of digital platforms led to the increased segment share.
  • North America had the highest revenue generated in 2022 for endocrine testing market. This is attributed to the vast presence of thyroid disorders, diabetes and obesity within the US population. Additionally, developed healthcare and increased spending pattern in this region also led to higher revenue generation.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Test Type
    • 1.1.2. Technology
    • 1.1.3. End-use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Test Type outlook
    • 2.2.2. Technology outlook
    • 2.2.3. End-use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Endocrine Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Endocrine Testing Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Endocrine Testing: Test Type Estimates & Trend Analysis

  • 4.1. Endocrine Testing Market: Key Takeaways
  • 4.2. Endocrine Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Estradiol (E2) Test
    • 4.3.1. Estradiol (E2) test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Follicle Stimulating Hormone (FSH) Test
    • 4.4.1. Follicle Stimulating Hormone (FSH) test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Human Chorionic Gonadotropin (hCG) Hormone Test
    • 4.5.1. Human Chorionic Gonadotropin (hCG) hormone test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Luteinizing Hormone (LH) Test
    • 4.6.1. Luteinizing Hormone (LH) test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Dehydroepiandrosterone Sulfate (DHEAS) Test
    • 4.7.1. Dehydroepiandrosterone Sulfate (DHEAS) test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.8. Progesterone Test
    • 4.8.1. Progesterone test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.9. Testosterone Test
    • 4.9.1. Testosterone test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.10. Thyroid Stimulating Hormone (TSH) Test
    • 4.10.1. Thyroid Stimulating Hormone (TSH) test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.11. Prolactin Test
    • 4.11.1. Prolactin test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.12. Cortisol Test
    • 4.12.1. Cortisol test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.13. Insulin Test
    • 4.13.1. Insulin test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.14. Others
    • 4.14.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Endocrine Testing: Technology Estimates & Trend Analysis

  • 5.1. Endocrine Testing Market: Key Takeaways
  • 5.2. Endocrine Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Tandem Mass Spectrometry
    • 5.3.1. Tandem mass spectrometry market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Immunoassay
    • 5.4.1. Immunoassay market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Monoclonal & Polyclonal Antibody Technologies
    • 5.5.1. Monoclonal & polyclonal antibody technologies market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Sensor Technology
    • 5.6.1. Sensor technology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Clinical Chemistry
    • 5.7.1. Clinical chemistry market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Endocrine Testing: End-use Estimates & Trend Analysis

  • 6.1. Endocrine Testing Market: Key Takeaways
  • 6.2. Endocrine Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Hospitals
    • 6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Commercial Laboratories
    • 6.4.1. Commercial laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Ambulatory Care Centers
    • 6.5.1. Ambulatory care centers market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Endocrine Testing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Endocrine Testing Market by Region: Key Marketplace Takeaway
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Sweden
      • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Norway
      • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. China
      • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. India
      • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. Saudi Arabia
      • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Market Participant Categorization
    • 8.2.1. Abbott Laboratories
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. AB Sciex
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Agilent Technologies Inc.
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. bioMerieux SA
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Bio-Rad Laboratories Inc.
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. DiaSorin S.p.A.
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. F. Hoffmann-La Roche Ltd.
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Laboratory Corporation of America Holdings
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Quest Diagnostics Incorporated
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Ortho Clinical Diagnostics
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 3 North America endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 4 North America endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 5 North America endocrine testing market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 7 U.S. endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 8 U.S. endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Canada endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 10 Canada endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 11 Canada endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 13 Europe endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 14 Europe endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Europe endocrine testing market, by region, 2018 - 2030 (USD Million)
  • Table 16 Germany endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 17 Germany endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Germany endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 UK endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 20 UK endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 21 UK endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 France endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 23 France endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 24 France endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Italy endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 26 Italy endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Italy endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Spain endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 29 Spain endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 30 Spain endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Sweden endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 32 Sweden endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Sweden endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Norway endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 35 Norway endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 36 Norway endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Denmark endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 38 Denmark endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 39 Denmark endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific endocrine testing market, by region, 2018 - 2030 (USD Million)
  • Table 44 China endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 45 China endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 46 China endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 Japan endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 48 Japan endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 49 Japan endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 India endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 51 India endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 52 India endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Australia endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 54 Australia endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 55 Australia endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 Thailand endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 57 Thailand endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 58 Thailand endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 South Korea endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 60 South Korea endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 61 South Korea endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Latin America endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 63 Latin America endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 64 Latin America endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 65 Latin America endocrine testing market, by region, 2018 - 2030 (USD Million)
  • Table 66 Brazil endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 67 Brazil endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 68 Brazil endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Mexico endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 70 Mexico endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 71 Mexico endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 72 Argentina endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 73 Argentina endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 74 Argentina endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa endocrine testing market, by region, 2018 - 2030 (USD Million)
  • Table 79 South Africa endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 80 South Africa endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 81 South Africa endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 UAE endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 86 UAE endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 87 UAE endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 89 Kuwait endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 90 Kuwait endocrine testing market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Endocrine testing: Market outlook
  • Fig. 9 Endocrine testing: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Endocrine testing market driver impact
  • Fig. 15 Endocrine testing market restraint impact
  • Fig. 16 Endocrine testing market strategic initiatives analysis
  • Fig. 17 Endocrine testing market: Test type movement analysis
  • Fig. 18 Endocrine testing market: Test type outlook and key takeaways
  • Fig. 19 Estradiol (E2) test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Follicle Stimulating Hormone (FSH) test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Human Chorionic Gonadotropin (hCG) hormone test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Luteinizing Hormone (LH) test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Dehydroepiandrosterone Sulfate (DHEAS) test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Progesterone test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Testosterone test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Thyroid Stimulating Hormone (TSH) test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Prolactin test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Cortisol test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Insulin test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Endocrine testing market: Technology movement analysis
  • Fig. 32 Endocrine testing market: Technology outlook and key takeaways
  • Fig. 33 Tandem mass spectrometry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Monoclonal & polyclonal antibody technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Sensor technology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Clinical chemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Endocrine testing market: End-use movement analysis
  • Fig. 40 Endocrine testing market: End-use outlook and key takeaways
  • Fig. 41 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Commercial laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Ambulatory care centers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Global endocrine testing market: Regional movement analysis
  • Fig. 46 Global endocrine testing market: Regional outlook and key takeaways
  • Fig. 47 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)